Skip to content
Survodutide 10 mg
Metabolic & Weight

Survodutide

GLP-1 / glucagon dual agonist.

$149.99
/ 10 mg
In stock — ships in 1–2 business days
Volume pricing
2–3
5%
4–6
10%
7–9
15%
10+
20%
US-basedHPLC-verifiedWhy crypto?

Crypto checkout · $15 US shipping, free over $199.

Research use only

For research and laboratory use only. Not for human or veterinary consumption.

99% · by HPLCHow we verify →

About this compound

Survodutide is a single-molecule GLP-1 and glucagon dual agonist engineered for a balanced, two-pathway metabolic signal. Built on a glucagon backbone with GLP-1 / exendin-derived substitutions and a fatty-diacid tail for extended stability, it unites appetite-and-glucose control with energy-expenditure activity in one purpose-built peptide.

Its glucagon-rooted design gives it particular research relevance to energy metabolism and hepatic function, while the GLP-1 substitutions add incretin-driven appetite and glucose benefits. The fatty-diacid tail supports a long-acting profile and steady signaling across the research window.

Supplied as a stable lyophilized powder, Survodutide is a leading single-molecule dual-agonist reference compound for energy-metabolism and hepatic research. For laboratory and research use only.

Research overview

  1. Single-molecule GLP-1 & glucagon agonism

    Survodutide combines GLP-1 and glucagon activity within one engineered molecule, built on a glucagon backbone with GLP-1 / exendin substitutions. This unified design delivers a coordinated dual-pathway signal. In research models, its single-molecule construction makes it a clean and reproducible tool for studying dual-agonist biology.

  2. Energy metabolism

    The glucagon foundation of Survodutide places energy metabolism and expenditure at the center of its research profile. Glucagon signaling is studied for its role in driving metabolic rate and mobilizing stored energy. This makes Survodutide a focal compound for energy-balance investigation.

  3. Hepatic research

    Survodutide draws significant research interest for its effects on hepatic function and liver-related metabolism, where glucagon signaling is highly active. By influencing hepatic energy and lipid handling, it is studied as a tool for liver-metabolism research. This hepatic focus is a defining feature of its research appeal.

  4. Appetite & glucose control

    The GLP-1 / exendin substitutions give Survodutide incretin-driven appetite and glucose-handling activity. This complements its glucagon-linked energy expenditure for a balanced metabolic effect. Together the pathways support comprehensive metabolic regulation in research settings.

  5. Long-acting stability

    Survodutide's fatty-diacid tail extends its half-life, supporting sustained receptor engagement across the research window. This long-acting design avoids the rapid clearance of shorter peptides and delivers steady, reproducible signaling. Its stability profile makes it well suited to longitudinal metabolic and hepatic study designs.

Research use only

All products are sold for laboratory and research use only and are not for human or veterinary consumption, diagnosis, or treatment of any kind. These statements have not been evaluated by the U.S. Food and Drug Administration. The products and statements are not intended to diagnose, treat, cure, or prevent any disease. Amino Meta is a chemical supplier and is not a compounding pharmacy or an outsourcing facility as defined under sections 503A and 503B of the Federal Food, Drug, and Cosmetic Act.

Add the essentials

Researcher reviews

No researcher reviews yet — verified buyers can review after ordering.

Volume pricing· Save 20%
$149.99